Oncomine India Private Limited

Oncomine India Private Limited - research & development in Mumbai, Maharashtra, India. FY 2026 financials and compliance.
CIN U73200MH2020FTC336744 Incorporated 28 January 2020 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Foreign Private Limited Company research and development
Data last updated
Revenue · FY 2022
-
Latest filing
EBITDA · FY 2022
*****
▲ 0.00% YoY
Net profit · FY 2022
*****
▲ 25.00% YoY
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
None
Secured borrowings
Company age
6 yrs
Est. 2020
Last financials
Mar 2025
Balance sheet date

About Oncomine India Private Limited

Data last updated: 11 March 2026

Oncomine India Private Limited is a foreign private limited company based in Mumbai, Maharashtra, India. It specialises in social science research, a part of the broader research and development sector. Incorporated on 28 January 2020, the company has been in operation for over 6 years.

Registered with ROC Mumbai under CIN U73200MH2020FTC336744.

Capital: an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Anumeha Soni and Manish Purshotam Sanghai.

Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: 403 – 404 B – Wing Delphi Hiranandani Business Park Powai, Mumbai, Maharashtra, India – 400076.

Company Details of Oncomine India Private Limited
CIN U73200MH2020FTC336744
Registration Number 336744
Incorporation Date 28 January 2020
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Key People
Anumeha Soni Director Manish Purshotam Sanghai Director Jitesh Kakaria Additional Director
Contact Details
  • Email
    *****@*****.com
  • Telephone
    **************
  • Website
    **************
  • Social Media
    **************
  • Registered Address
    403 – 404 B – Wing Delphi Hiranandani Business Park Powai, Mumbai, Maharashtra, India – 400076
  • Industry
    Research & Development, Social Science Research
Company report
Oncomine India Private Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Oncomine India Private Limited report

Financials, compliance, directors, charges, ownership and filings for Oncomine India Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

Board of Directors of Oncomine India Private Limited

Oncomine India Private Limited is currently managed by 4 directors, with 6 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Anumeha Soni
Also directs: Thermo Fisher Scientific India Private Limited
Director 13 Aug 2022 3 Years 10 Months Current
Manish Purshotam Sanghai Director 03 Jan 2024 2 Years 6 Months Current
Jitesh Kakaria
Also directs: Thermo Fisher Scientific India Private Limited
Additional Director 13 Jan 2026 0 Years 5 Months Current
Dibyendu Chakrabarti Thakur Additional Director 13 Jan 2026 0 Years 5 Months Current
View all directors

Financials of Oncomine India Private Limited FY 2025 filings available

Oncomine India Private Limited reported revenue of ₹- (up ) for FY 2022. Profit growth despite declining revenue indicates effective cost management and margin discipline.

Revenue
-
Profit
***** ▲ 25.00%
EBITDA
*****
Metrics
*****
*****
*****
*****
*****
Revenue
Revenue from Operations
*****
*****
*****
*****
*****
Revenue Growth %
*****
*****
*****
*****
*****
Other Income
*****
*****
*****
*****
*****
Total Revenue
*****
*****
*****
*****
*****
Expenses
Total Expenses
*****
*****
*****
*****
*****
Raw Material Cost
*****
*****
*****
*****
*****
Change in Inventory FG
*****
*****
*****
*****
*****
Change in Inventory WIP
*****
*****
*****
*****
*****
Purchase of Traded Goods
*****
*****
*****
*****
*****
Employee Cost
*****
*****
*****
*****
*****
Managerial Remuneration
*****
*****
*****
*****
*****
Audit Fees
*****
*****
*****
*****
*****
Insurance
*****
*****
*****
*****
*****
Power & Fuel
*****
*****
*****
*****
*****
Interest
*****
*****
*****
*****
*****
Depreciation
*****
*****
*****
*****
*****
Other Expenses
*****
*****
*****
*****
*****
Profitability
EBITDA (Operating Profit)
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
Exceptional Items
*****
*****
*****
*****
*****
Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Exceptional & Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Tax
*****
*****
*****
*****
*****
Tax & Net Profit
Tax Expense
*****
*****
*****
*****
*****
Current Tax
*****
*****
*****
*****
*****
Deferred Tax
*****
*****
*****
*****
*****
Profit from Discontinued Operations
*****
*****
*****
*****
*****
Tax on Discontinued Operations
*****
*****
*****
*****
*****
Profit
*****
*****
*****
*****
*****
Net Margin %
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Shareholders' Funds
Total Shareholders' Funds
*****
*****
*****
*****
*****
Equity Capital
*****
*****
*****
*****
*****
Reserves & Surplus
*****
*****
*****
*****
*****
Money Against Warrants
*****
*****
*****
*****
*****
Other Equity
*****
*****
*****
*****
*****
Non-Current Liabilities
Total Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Borrowings
*****
*****
*****
*****
*****
Deferred Tax Liabilities
*****
*****
*****
*****
*****
Other Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Provisions
*****
*****
*****
*****
*****
Current Liabilities
Total Current Liabilities
*****
*****
*****
*****
*****
Short-Term Borrowings
*****
*****
*****
*****
*****
Trade Payables
*****
*****
*****
*****
*****
Other Current Liabilities
*****
*****
*****
*****
*****
Short-Term Provisions
*****
*****
*****
*****
*****
Total Equity & Liabilities
*****
*****
*****
*****
*****
Non-Current Assets
Non-Current Assets
*****
*****
*****
*****
*****
Tangible Assets
*****
*****
*****
*****
*****
Intangible Assets
*****
*****
*****
*****
*****
Capital WIP
*****
*****
*****
*****
*****
Intangibles Under Dev
*****
*****
*****
*****
*****
Investments
*****
*****
*****
*****
*****
Deferred Tax Assets
*****
*****
*****
*****
*****
LT Loans & Advances
*****
*****
*****
*****
*****
Other Non-Current Assets
*****
*****
*****
*****
*****
Current Assets
Current Assets
*****
*****
*****
*****
*****
Current Investments
*****
*****
*****
*****
*****
Inventories
*****
*****
*****
*****
*****
Trade Receivables
*****
*****
*****
*****
*****
Cash & Bank Balance
*****
*****
*****
*****
*****
ST Loans & Advances
*****
*****
*****
*****
*****
Other Current Assets
*****
*****
*****
*****
*****
Total Assets
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Cash from Operating Activities (CFO)
Profit Before Tax
*****
*****
*****
*****
*****
Non-Cash Adjustments
*****
*****
*****
*****
*****
+ Interest Expense
*****
*****
*****
*****
*****
+ Depreciation
*****
*****
*****
*****
*****
+/- Unrealized Forex
*****
*****
*****
*****
*****
- Dividend Income
*****
*****
*****
*****
*****
- Interest Income
*****
*****
*****
*****
*****
+/- Other Non-Cash Items
*****
*****
*****
*****
*****
Changes in Working Capital
*****
*****
*****
*****
*****
+/- Inventory
*****
*****
*****
*****
*****
+/- Debtors
*****
*****
*****
*****
*****
+/- Creditors
*****
*****
*****
*****
*****
Reconciliation Adjustments
*****
*****
*****
*****
*****
Cash Generated from Operations
*****
*****
*****
*****
*****
Income Taxes Paid
*****
*****
*****
*****
*****
Net CFO (Cash from Operations)
*****
*****
*****
*****
*****
Cash from Investing Activities (CFI)
Acquisitions & Disposals
*****
*****
*****
*****
*****
Disposal of Subsidiaries
*****
*****
*****
*****
*****
Acquisition of Subsidiaries
*****
*****
*****
*****
*****
Capex
*****
*****
*****
*****
*****
Purchase of Fixed Assets
*****
*****
*****
*****
*****
Sale of Fixed Assets
*****
*****
*****
*****
*****
Other Investing Cash Flows
*****
*****
*****
*****
*****
Net CFI (Cash from Investing)
*****
*****
*****
*****
*****
Cash from Financing Activities (CFF)
Equity Issuance
*****
*****
*****
*****
*****
Debt Raised
*****
*****
*****
*****
*****
Debt Repaid
*****
*****
*****
*****
*****
Dividends Paid
*****
*****
*****
*****
*****
Interest Paid
*****
*****
*****
*****
*****
Net CFF (Cash from Financing)
*****
*****
*****
*****
*****
Net Cash Position
Net Change in Cash (Pre-Forex)
*****
*****
*****
*****
*****
Closing Cash & Equivalents
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Liquidity
Current Ratio
*****
*****
*****
*****
*****
Quick Ratio
*****
*****
*****
*****
*****
Cash Ratio
*****
*****
*****
*****
*****
Efficiency
Inventory Days
*****
*****
*****
*****
*****
Debtor Days
*****
*****
*****
*****
*****
Creditor Days
*****
*****
*****
*****
*****
Cash Conversion Cycle
*****
*****
*****
*****
*****
Asset Turnover
*****
*****
*****
*****
*****
Profitability
Net Profit Margin %
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
ROE %
*****
*****
*****
*****
*****
ROCE %
*****
*****
*****
*****
*****
Net Worth Margin %
*****
*****
*****
*****
*****
Growth
Revenue Growth %
*****
*****
*****
*****
*****
Leverage
Equity Multiplier
*****
*****
*****
*****
*****
Debt / EBITDA
*****
*****
*****
*****
*****
Solvency
D/E Ratio
*****
*****
*****
*****
*****
ICR
*****
*****
*****
*****
*****

Consolidated Statements

Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.

Unlock Complete Financial History (FY 2015 – Latest)
Standalone & Consolidated - Income Statement, Balance Sheet, Cash Flow, Financial Ratios and Growth Trends with 10+ years of line-item data.
10+ years of data Line-item breakdown Balance Sheet detail Cash Flow analysis 20+ ratios & metrics Downloadable PDF
What Is the Ownership and Shareholding Structure of Oncomine India Private Limited?

View Oncomine India Private Limited's control and ownership data: shareholding patterns, funding details, FII information, directors and KMP remuneration, group structure, overseas investment and related data.

Shareholding Pattern (FY 2026)
Shareholding pattern chart
  • Promoters: **.**%
  • Public: **.**%
  • Others: **.**%
Shareholding Pattern over the Year
FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Promoters**.****.****.****.****.**
Public**.****.****.****.****.**
Others**.****.****.****.****.**

Full shareholding pattern with quarterly trends.

Charges & Borrowings Oncomine India Private Limited

Oncomine India Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Oncomine India Private Limited

View historical data on people associated with Oncomine India Private Limited, including employment history and EPFO contributions.

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of Oncomine India Private Limited

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of Oncomine India Private Limited

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of Oncomine India Private Limited

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for Oncomine India Private Limited

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay - Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of Oncomine India Private Limited

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by Oncomine India Private Limited

MSME Payment Delays by Oncomine India Private Limited

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of Oncomine India Private Limited

Subsidiaries & Group Companies of Oncomine India Private Limited

See the full corporate group - holding company, subsidiaries, associates and joint ventures of Oncomine India Private Limited with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of Oncomine India Private Limited

MCA Filings & Documents of Oncomine India Private Limited

Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on Oncomine India Private Limited

Directors
13 Jan 2026
Jitesh Kakaria was appointed as a Additional Director on 13 Jan 2026 & has been associated with this company since 5 months 28 days.
Directors
13 Jan 2026
Dibyendu Chakrabarti Thakur was appointed as a Additional Director on 13 Jan 2026 & has been associated with this company since 5 months 28 days.
Activity
30 Sep 2025
Oncomine India Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Activity
31 Mar 2025
Oncomine India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Directors
03 Jan 2024
Manish Purshotam Sanghai was appointed as a Director on 03 Jan 2024 & has been associated with this company since 2 years 6 months.
Directors
13 Aug 2022
Anumeha Soni was appointed as a Director on 13 Aug 2022 & has been associated with this company since 3 years 10 months.

Frequently Asked Questions about Oncomine India Private Limited

Oncomine India Private Limited is an active foreign private limited company in the research and development sector based in Mumbai, Maharashtra, India. It was incorporated on 28 January 2020 (6+ years old) and is registered under CIN U73200MH2020FTC336744.

The current directors of Oncomine India Private Limited are:

The primary industry of Oncomine India Private Limited is research and development. The company specifically operates in social science research. The company is currently active in this sector.

Oncomine India Private Limited can be reached at the registered office: 403 – 404 B – Wing Delphi Hiranandani Business Park Powai, Mumbai, Maharashtra, India – 400076.

The authorised capital is ₹1 Lakh, and the paid-up capital is ₹1 Lakh.

The company has its registered office at 403 – 404 B – Wing Delphi Hiranandani Business Park Powai, Mumbai, Maharashtra, India – 400076.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available